Recursion Pharmaceuticals (NASDAQ:RXRX) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.01), Briefing.com reports. The company had revenue of $26.08 million for the quarter, compared to analyst estimates of $12.62 million. Recursion Pharmaceuticals had a negative net […]
More Stories
Kelly Osbourne Movies and TV Shows: Appearance at the 2026 BRIT Awards
Kelly Osbourne is popularly known as the daughter of the late English singer and songwriter, John Michael “Ozzy” Osbourne. She...
Moon Mission on Track for April 1 Launch: NASA
By T.J. Muscaro CAPE CANAVERAL, Fla.—NASA leadership confirmed on March 12 that they were targeting 6:24 p.m. on April 1...
US Aerial Refueling Aircraft Crashes in Western Iraq
By Ryan Morgan A U.S. aerial refueling aircraft went down in western Iraq, the U.S. Central Command (CENTCOM) announced March...
Tech Giant Atlassian to Cut 1,600 Jobs in Artificial Intelligence Drive
By Monica O’Shea Software giant and tech unicorn Atlassian will slash about 1,600 jobs to make way for artificial intelligence...
Iran’s New Leader Issues First Statement, Says Hormuz Closure Should Be Used as Leverage
By Evgenia Filimianova Iran’s newly appointed leader, Ayatollah Mojtaba Khamenei, said on March 12 that the Strait of Hormuz must...
Police Respond to Active Shooter Incident at Synagogue in Michigan
By Jacki Thrapp Police responded to an active shooter incident at the Temple Israel synagogue in West Bloomfield Township in...